Novel drug-independent sedation level estimation based on machine learning of quantitative frontal electroencephalogram features in healthy volunteersRamaswamy, S. M., Kuizenga, M. H., Weerink, M. A. S., Vereecke, H. E. M., Struys, M. M. R. F. & Nagaraj, S. B., Oct-2019, In : British Journal of Anaesthesia. 123, 4, p. 479-487 9 p.
Research output: Contribution to journal › Article › Academic › peer-review
BACKGROUND: Sedation indicators based on a single quantitative EEG (QEEG) feature have been criticised for their limited performance. We hypothesised that integration of multiple QEEG features into a single sedation-level estimator using a machine learning algorithm could reliably predict levels of sedation, independent of the sedative drug used.
METHODS: In total, 102 subjects receiving propofol (N=36; 16 male/20 female), sevoflurane (N=36; 16 male/20 female), or dexmedetomidine (N=30; 15 male/15 female) were included in this study of healthy volunteers. Sedation level was assessed using the Modified Observer's Assessment of Alertness/Sedation (MOAA/S) score. We used 44 QEEG features estimated from the EEG data in a logistic regression algorithm, and an elastic-net regularisation method was used for feature selection. The area under the receiver operator characteristic curve (AUC) was used to assess the performance of the logistic regression model.
RESULTS: The performances obtained when the system was trained and tested as drug-dependent mode to distinguish between awake and sedated states (mean AUC [standard deviation]) were propofol=0.97 (0.03), sevoflurane=0.74 (0.25), and dexmedetomidine=0.77 (0.10). The drug-independent system resulted in mean AUC=0.83 (0.17) to discriminate between the awake and sedated states.
CONCLUSIONS: The incorporation of large numbers of QEEG features and machine learning algorithms is feasible for next-generation monitors of sedation level. Different QEEG features were selected for propofol, sevoflurane, and dexmedetomidine groups, but the sedation-level estimator maintained a high performance for predicting MOAA/S independent of the drug used.
CLINICAL TRIAL REGISTRATION: NCT02043938; NCT03143972.
|Number of pages||9|
|Journal||British Journal of Anaesthesia|
|Publication status||Published - Oct-2019|